Home›Stock Screener›Phaarmasia›Financial Statements

Phaarmasia Complete Financial Statements

12 Years of Data
2026 - 2015

In FYNone, Phaarmasia (PHRMASI) reported revenue ₹69 Cr, net profit ₹18 Cr and EPS ₹25.80, with a net profit margin of 37.5% and ROE of 81.8%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Phaarmasia share price today.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 37.50% 2026 data
EBITDA Margin 6.25% 2026 data
Operating Margin 4.00% 2026 data
Return on Assets 60.00% 2026 data
Return on Equity 81.82% 2026 data

Balance Sheet Ratios

Equity Ratio 73.33% 2026 data
Asset Turnover 1.60 2026 data

PHRMASI Revenue, Net Profit & EBITDA — Year-on-Year Growth

PHRMASI YoY (March 2026 vs Period) — revenue +43.8%, EBITDA +633.3%, expenses +4.4%.

Revenue Growth
+43.8%
Year-over-Year
EBITDA Growth
+633.3%
Year-over-Year
Expense Growth
+4.4%
Year-over-Year
Assets Growth
+36.4%
Year-over-Year
Equity Growth
+144.4%
Year-over-Year
Operating Cash Flow Growth
+833.3%
Year-over-Year

PHRMASI Income Statement — Revenue, EBITDA & Net Profit

Phaarmasia revenue ₹69 Cr, EBITDA ₹22 Cr, net profit ₹18 Cr, EPS ₹25.80 (None) — net profit margin 37.5%. Compare with PHRMASI fundamental valuation to assess whether the stock is under or overvalued.

Periods ₹ Crores
Particulars None March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 69 48 25 31 28 18 21 25 25 21 15 22 19
Expenses 47 45 26 31 29 19 20 24 24 20 14 21 18
EBITDA 22 3 -1 0 -1 -1 1 1 1 1 1 1 1
Operating Profit Margin % 2.00% 4.00% -8.00% -3.00% -6.00% -10.00% 0.00% 3.00% 3.00% 3.00% 1.00% 1.00% 5.00%
Depreciation 0 0 0 0 0 0 0 0 1 1 0 1 1
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 21 21 -2 -1 -1 -2 1 1 1 1 0 0 0
Tax 4 4 0 0 0 0 0 0 0 0 0 0 0
Net Profit 18 18 -2 -1 -1 -2 0 1 1 1 0 0 0
Earnings Per Share (₹) 25.80 25.74 -2.33 -0.76 -1.84 -2.27 0.46 0.79 1.14 0.84 0.24 0.06 0.20

PHRMASI Balance Sheet — Assets, Liabilities & Shareholders' Equity

PHRMASI total assets ₹30 Cr, total equity ₹22 Cr, total liabilities ₹ Cr (2026) — ROE 81.8%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 30 22 31 28 21 22 34 33 22 20 19 19
Current Assets 27 8 18 15 8 9 20 19 8 6 4 4
Fixed Assets 1 12 13 13 13 13 13 14 14 14 14 16
Capital Work in Progress 0 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0
Other Assets 29 9 19 16 8 9 20 20 8 6 5 4
LIABILITIES
Total Liabilities
Current Liabilities 0 0 0 0 0 0 1 1 1 1 1 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 22 9 10 11 12 14 13 13 12 12 12 13
Share Capital 7 7 7 7 7 7 7 7 7 7 7 7
Reserves & Surplus 15 2 4 4 5 7 7 6 5 5 5 6

PHRMASI Cash Flow Statement — Operating, Investing & Financing

Phaarmasia operating cash flow ₹22 Cr, investing ₹-12 Cr, financing ₹1 Cr, net cash flow ₹11 Cr (2026).

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 22 -3 0 1 0 0 0 0 1 0 0 1
Investing Activities -12 0 0 0 0 0 0 0 -1 0 0 0
Financing Activities 1 0 0 0 0 0 0 0 0 0 0 0
Net Cash Flow 11 -3 0 1 0 0 0 0 0 0 0 0